Xingjuan Chang

Title: Innovations of Xingjuan Chang in Pharmaceutical Development

Introduction

Xingjuan Chang is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystalline forms of Resmetirom. His work focuses on improving the properties of drugs used for treating various health conditions.

Latest Patents

Xingjuan Chang holds a patent for "Resmetirom crystal, preparation method for same, and uses thereof." This patent describes novel crystalline forms of Resmetirom, referred to as “Compound I.” The preparation methods, pharmaceutical compositions containing these crystalline forms, and their uses for developing THR-β selective agonist drugs and treatments for NASH and HeFH are detailed in the patent. Compared to prior arts, the crystalline forms of Compound I exhibit one or more improved properties, which are valuable for optimizing and developing drugs containing this compound.

Career Highlights

Xingjuan Chang is associated with Crystal Pharmaceutical (Suzhou) Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential impact on drug development and treatment efficacy.

Collaborations

Xingjuan Chang collaborates with Minhua Chen, who is also a key figure in his research endeavors. Their partnership enhances the innovative capacity of their projects and contributes to the advancement of pharmaceutical sciences.

Conclusion

Xingjuan Chang's contributions to the field of pharmaceuticals, particularly through his patent on Resmetirom, highlight his role as an influential inventor. His work not only improves drug properties but also paves the way for future advancements in medical treatments.